Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAF(V599lns))
- PMID: 16402937
- DOI: 10.1111/j.1365-2265.2005.02401.x
Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAF(V599lns))
Abstract
Objectives: The genes RET and RAS, and more recently BRAF, have been shown to be frequently mutated in human papillary thyroid carcinomas (PTC). The aim of this study was to genotype for these mutations a cohort of thyroid tumours collected at our institutions.
Design and patients: Thyroid tumours removed from 51 subjects were analysed, including 43 PTC and 8 non-PTC tumours [3 follicular adenomas (FA), 4 follicular carcinomas (FTC) and 1 anaplastic carcinoma (AC)].
Measurements: RET/PTC1 and RET/PTC3 expression was evaluated by reverse transcriptase-polymerase chain reaction, whereas screening of BRAF (exon 15) and RAS (HRAS, KRAS2 and NRAS) mutations were performed, respectively, by single strand conformation polymorphism and denaturing high-pressure liquid chromatography.
Results: RET/PTC expressions was positive in 5/43 (11.6%) PTC and in none of the non-PTC tumour. Similarly, BRAF mutations were positive only in PTC, but with a higher prevalence (24/43 positives, 55.8%). All but one BRAF mutation resulted in the prototypic substitution of valine 600 with a glutamic acid. In one case, a somatic in-frame insertion of three bases at codon 599 resulted in the insertion of an additional valine. RET/PTC expression and BRAF mutations were mutually exclusive. Screening of the RAS gene allowed identification of oncogenic mutations in 1/3 (33.3%) FA and 3/4 (75%) FTC. None of the PTCs was positive for RAS.
Conclusions: These data indicate that BRAF mutations are the most frequent genetic event in PTC and that RAS mutations, besides being a genetic hallmark of follicular tumours, are rare or completely absent in PTC from our area. Together, BRAF mutations and rarer RET rearrangements accounted for a genetic event in two-thirds of PTCs. This study showed a novel and presumably oncogenic mutation of BRAF, which is BRAF(V599Ins).
Similar articles
-
Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.Cancer. 2005 Jun 1;103(11):2261-8. doi: 10.1002/cncr.21073. Cancer. 2005. PMID: 15880523 Review.
-
[Molecular analysis of structural abnormalities in papillary thyroid carcinoma gene].Mol Biol (Mosk). 2004 Jul-Aug;38(4):642-53. Mol Biol (Mosk). 2004. PMID: 15456136 Russian.
-
BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC.Oncogene. 2003 Jul 17;22(29):4578-80. doi: 10.1038/sj.onc.1206706. Oncogene. 2003. PMID: 12881714
-
High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines.Cancer Res. 2003 Aug 1;63(15):4561-7. Cancer Res. 2003. PMID: 12907632
-
[BRAF gene mutation in thyroid cancer].Pol Merkur Lekarski. 2006 Feb;20(116):210-3. Pol Merkur Lekarski. 2006. PMID: 16708643 Review. Polish.
Cited by
-
Automated universal BRAF state detection within the activation segment in skin metastases by pyrosequencing-based assay U-BRAF(V600).PLoS One. 2013;8(3):e59221. doi: 10.1371/journal.pone.0059221. Epub 2013 Mar 26. PLoS One. 2013. PMID: 23555633 Free PMC article.
-
Thyroid cancer: current molecular perspectives.J Oncol. 2010;2010:351679. doi: 10.1155/2010/351679. Epub 2010 Mar 29. J Oncol. 2010. PMID: 20369062 Free PMC article.
-
Molecular genetics and diagnosis of thyroid cancer.Nat Rev Endocrinol. 2011 Aug 30;7(10):569-80. doi: 10.1038/nrendo.2011.142. Nat Rev Endocrinol. 2011. PMID: 21878896 Review.
-
Low VHL mRNA expression is associated with more aggressive tumor features of papillary thyroid carcinoma.PLoS One. 2014 Dec 9;9(12):e114511. doi: 10.1371/journal.pone.0114511. eCollection 2014. PLoS One. 2014. PMID: 25490036 Free PMC article.
-
A novel complex BRAF mutation detected in a solid variant of papillary thyroid carcinoma.Endocr Pathol. 2009 Summer;20(2):122-6. doi: 10.1007/s12022-009-9073-3. Endocr Pathol. 2009. PMID: 19370421
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous